|
|
Identification of optimum spectacle prescriptions for patients with Down syndrome |
| 5R01EY024590-08 |
|
NEI |
2022 |
|
|
Applications of high resolution fMRI in ultra-high field (7T) in revealing developmental disorders underlying amblyopia |
| 5R01EY030434-03 |
|
NEI |
2022 |
|
|
Abnormal HIF signaling in Down syndrome-related pulmonary hypertension |
| 1R21HL165364-01 |
|
NHLBI |
2022 |
|
|
Dissecting SARS-CoV-2 infection in Down syndrome with congenital heart defects using patient-specific iPSCs |
| 1R21HL165406-01 |
|
NHLBI |
2022 |
|
|
type I interferon regulates angiogenesis in Down Syndrome |
| 1R21HL165411-01 |
|
NHLBI |
2022 |
|
|
Dual-action drug coated balloon to mitigate neointimal hyperplasia and promote endothelialization. |
| 1R43HL160311-01A1 |
|
NHLBI |
2022 |
|
|
A universal ambient air-oxygen blender to treat respiratory distress in newborns |
| 1R43HL162270-01 |
|
NHLBI |
2022 |
|
|
Type I IFN signaling during lung development in Down Syndrome-Multiome sequencing of human fetal and pediatric trisomy 21 lungs |
| 3R01HL155104-01A1S1 |
|
NHLBI |
2022 |
|
|
Development of a Polymeric Percutaneous Pulmonary Valve for Use in Young Children |
| 3R44HL129577-03S1 |
|
NHLBI |
2022 |
|
|
Development of a Polymeric Percutaneous Pulmonary Valve for Use in Young Children |
| 3R44HL129577-03S2 |
|
NHLBI |
2022 |